Clinical Trial Update: The Comparative Efficacy of Standard Treatment Plus Ribavirin vs Standard Treatment Alone in Preventing Clinically Significant Hemorrhage in Patients With Dengue Fever [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating whether adding ribavirin to standard dengue treatment reduces clinically significant hemorrhage compared with standard treat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue
• Dengue Fever
• Dengue Hemorrhagic Fever

Drugs mentioned

• Ribavirin (ribavirin)

Snippet

Sponsor: Khyber Medical University Peshawar | Conditions: Dengue Fever, Dengue Hemorrhagic Fever | Phase 3 | Status: COMPLETED